Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Josh Vogel - VP, IR John Martins - President and CEO Bill Burns - EVP and CFO Marc Krug - Group President, Delivery Daniel White - CCO Conference Call Participants Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Brian Tanquilut - Jefferies Tobey Sommer - Truist Securities Kevin Steinke - Barrington Research Good afternoon, everyone. Welcome to the Cross Country Healthcar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2022 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From _________ to _________ ——————— CROSS COUNTRY HEALTHCARE, INC. (Exact name of registrant as specified in its charter) ——————— Delaware 0-33169 13-406622 ...

Q2 2022 Investor Relations September 2022 Forward Looking Statements This presentation contains forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", "appears","seeks", "will" and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncert ...

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q2 2022 Earnings Conference Call August 3, 2022 5:00 PM ET Company Participants Josh Vogel - Vice President, Investor Relations John A. Martins - President and Chief Executive Officer William J. Burns - Executive Vice President and Chief Financial Officer Daniel J. White - Chief Commercial Officer Conference Call Participants Kevin Fischbeck - Bank of America Taji Phillips - Jefferies Financial Group Inc. Tobey Sommer - Truist Securities William Sutherland - The ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2022 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From _________ to _________ ——————— CROSS COUNTRY HEALTHCARE, INC. (Exact name of registrant as specified in its charter) ——————— Delaware 0-33169 13-4066229 (St ...

Q1 2022 Investor Relations June 2022 Forward Looking Statements This presentation contains forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", "appears","seeks", "will" and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainti ...

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants John A. Martins – President and Chief Executive Officer William J. Burns – Executive Vice President and Chief Financial Officer Daniel J. White – Chief Commercial Officer Marc Krug – Group President, Delivery Josh Vogel – Vice President, Investor Relations Conference Call Participants Kevin Fischbeck – Bank of America Merrill Lynch International Limited Brian Tanquilut – Jefferies Financ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2022 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From _________ to _________ ——————— CROSS COUNTRY HEALTHCARE, INC. (Exact name of registrant as specified in its charter) ——————— Delaware 0-33169 13-4066229 (S ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 0-33169 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 13-4 ...

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET Company Participants William Burns - CFO Kevin Clark - CEO John Martins - Group President, Delivery Buffy White - Group President, Workforce Solutions Conference Call Participants A.J. Rice - Credit Suisse Tobey Sommer - Truist Securities Courtney Fondufe - Bank of America Brian Tanquilut - Jefferies Operator Good afternoon, everyone. Welcome to the Cross Country Healthcare's Earnings Conference Call f ...